Dokument: Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients

Titel:Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=69620
URN (NBN):urn:nbn:de:hbz:061-20250512-112815-9
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Jäger, Paul [Autor]
Biermann, Benno [Autor]
Liebers, Nora [Autor]
Schulz, Felicitas [Autor]
Baermann, Ben-Niklas [Autor]
Twarock, Sören [Autor]
Geyh, Stefanie [Autor]
Nachtkamp, Kathrin [Autor]
Tressin, Patrick [Autor]
Kasprzak, Annika [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]1,28 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 12.05.2025 / geändert 12.05.2025
Stichwörter:cellular therapies, hematological malignancies, transplant, BMT
Beschreibung:Background: Allogeneic hematopoietic stem cell transplantation (allo-SCT) is a key treatment for hematologic malignancies, but donor selection impacts outcomes.
Results: In a cohort of 152 patients undergoing allo-SCT from 2012 to 2023, haploidentical donors with post-transplant cyclophosphamide (PTCy) showed superior survival compared to 9/10 mismatched unrelated donors (MMUD). Cox regression analysis revealed that patients not in complete remission (CR) before transplantation particularly benefited from haplo donors, while those with 9/10 MMUD and lacking CR had worse outcomes.
Conclusion: These results highlight the importance of donor selection, suggesting that haplo donors with PTCy may be preferable for patients not in CR, necessitating alternative approaches for others.
Clinical trial registration: The authors have confirmed clinical trial registration is not needed for this submission.
Rechtliche Vermerke:Originalveröffentlichung:
Jäger, P. S., Biermann, B., Liebers, N., Schulz, F., Bärmann, B.-N., Twarock, S., Geyh, S., Nachtkamp, K., Tressin, P., Kasprzak, A., Matkey, F., Watrin, T., El Yaouti, M., Germing, U., Dietrich, S., & Kobbe, G. (2025). Haploidentical Allogeneic Stem Cell Transplantation as a Superior Alternative for Patients With Mismatch Donors—A Single Center Experience in 152 Patients. EJHaem [ISSN: 2688-6146], 6(2). https://doi.org/10.1002/jha2.70012
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:12.05.2025
Dateien geändert am:12.05.2025
english
Benutzer
Status: Gast
Aktionen